GABAPENTIN

Product NDC: 31722-148
11-digit product format: 317220148
Labeler code: 31722
Product ID: 31722-148_2a2c08de-b06c-4926-e063-6394a90a2eb0
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: gabapentin
Dosage form: CAPSULE
Route: ORAL
Labeler: Camber Pharmaceuticals, Inc.
Application: ANDA214956
Marketing category: ANDA
Marketing start: 2021-05-10
Substance: GABAPENTIN
Active strength: 100 mg/1
Pharmacologic classes: Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A214956-001	GABAPENTIN	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2021-05-10
A214956-002	GABAPENTIN	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2021-05-10
A214956-003	GABAPENTIN	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2021-05-10

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
A214956-001	AB
A214956-002	AB
A214956-003	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 99 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A214956-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2021-05-10	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A214956-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2021-05-10	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A214956-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2021-05-10	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A214956-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2021-05-10	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A214956-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2021-05-10	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A214956-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2021-05-10	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A214956-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2021-05-10	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A214956-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2021-05-10	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A214956-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2021-05-10	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A214956-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2021-05-10	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A214956-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2021-05-10	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A214956-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2021-05-10	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A214956-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2021-05-10	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A214956-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2021-05-10	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A214956-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2021-05-10	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A214956-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2021-05-10	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A214956-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2021-05-10	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A214956-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2021-05-10	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A214956-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2021-05-10	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A214956-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2021-05-10	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A214956-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2021-05-10	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A214956-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2021-05-10	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A214956-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2021-05-10	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A214956-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2021-05-10	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A214956-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2021-05-10	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A214956-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2021-05-10	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A214956-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2021-05-10	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A214956-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2021-05-10	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A214956-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2021-05-10	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A214956-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2021-05-10	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A214956-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2021-05-10	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A214956-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2021-05-10	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A214956-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2021-05-10	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A214956-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2021-05-10	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A214956-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2021-05-10	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A214956-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2021-05-10	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A214956-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2021-05-10	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A214956-002	GABAPENTIN	300MG	CAPSULE / ORAL	AB	2021-05-10	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A214956-003	GABAPENTIN	400MG	CAPSULE / ORAL	AB	2021-05-10	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A214956-001	GABAPENTIN	100MG	CAPSULE / ORAL	AB	2021-05-10	`8072bd15b7f6…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 99 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A214956-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A214956-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A214956-003	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A214956-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A214956-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A214956-003	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A214956-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A214956-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A214956-003	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A214956-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A214956-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A214956-003	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A214956-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A214956-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A214956-003	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A214956-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A214956-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A214956-003	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A214956-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A214956-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A214956-003	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A214956-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A214956-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A214956-003	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A214956-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A214956-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A214956-003	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A214956-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A214956-002	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A214956-003	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A214956-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A214956-002	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A214956-003	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A214956-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A214956-002	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A214956-003	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A214956-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A214956-002	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A214956-003	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A214956-001	AB	1	`8072bd15b7f6…`

Additional Listing Data#

Finished product: Yes
Brand name base: GABAPENTIN
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
GABAPENTIN	100 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
6CW7F3G59X	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 3 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
310430	Internal RxNorm lookup
310431	Internal RxNorm lookup
310432	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
e8a30eb7-3fc5-456a-bdae-3f4095bf2c2b	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
cdc2ae60-922e-452d-a42f-787fe4e2ed06	Product name	1	20250123
7059096a-4b9f-36c2-db50-bb5c723e6e9e	Product name	2	20250114
6c13b22c-b3ba-4127-b768-0132dd5ab0d1	Product name	1	20230829
594e2c86-3079-4e6e-96c9-48f7a8afc78d	Product name	1	20230718
a62a50ac-1535-4461-9768-8ae703e2e9fb	Product name	1	20210525
fa3f0129-3502-889f-f424-3a37727959e7	Product name	9	20181206
77d89e4c-f57f-326d-d7aa-787f8eebbd2b	Product name	1	20140508
9514609b-a2a9-f8ec-6ba6-3f8e5ee89877	Product name	1	20140508
bc07ef78-e82d-0c19-31f4-31f263780582	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
31722-148-01	GABAPENTIN	100 in 1 BOTTLE	CAPSULE	100	3
31722-148-05	GABAPENTIN	500 in 1 BOTTLE	CAPSULE	500	3
31722-148-10	GABAPENTIN	1000 in 1 BOTTLE	CAPSULE	1000	3

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
31722-148-01	EA - Each	31722-148	8ee5421d-87f9-4b31-bfb9-0bf3bea0c67d	1	2021-12-08
31722-148-05	EA - Each	31722-148	32c65afb-2b61-4fd8-85b1-9b1f348170e6	1	2021-12-08
31722-148-10	EA - Each	31722-148	771a1206-2de1-4609-a88a-0302a82361d7	1	2021-12-08

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
31722-148	GABAPENTIN (GABAPENTIN) CAPSULE [CAMBER PHARMACEUTICALS, INC.]	3	Current NDC, Legacy NDC, 3 package rows	20241228_e8a30eb7-3fc5-456a-bdae-3f4095bf2c2b.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 16 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
GABAPENTIN	GABAPENTIN	St. Mary's Medical Park Pharmacy	235a6954-318a-9e3a-e063-6394a90a0e21	2026-06-19	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 214956 application number: ANDA214956
GABAPENTIN	GABAPENTIN	Preferred Pharmaceuticals Inc.	dd0e12c2-1986-4ca3-a809-d703a7542419	2026-04-22	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 214956 application number: ANDA214956
GABAPENTIN	GABAPENTIN	A-S Medication Solutions	4aa69d04-6b32-4764-a48b-ef5313dd95d3	2026-01-23	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 214956 application number: ANDA214956
GABAPENTIN	GABAPENTIN	A-S Medication Solutions	43a3ec78-8235-4d46-a343-2f9226745a39	2026-01-23	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 214956 application number: ANDA214956
GABAPENTIN	GABAPENTIN	A-S Medication Solutions	685553b0-384e-400b-a8ae-612ceece8261	2026-01-22	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 214956 application number: ANDA214956
GABAPENTIN	GABAPENTIN	A-S Medication Solutions	7ea0b220-edbb-45eb-aeb3-65283f8489a1	2026-01-22	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 214956 application number: ANDA214956
GABAPENTIN	GABAPENTIN	Northwind Health Company, LLC	47214c7c-ba1b-9107-e063-6294a90a5431	2025-12-29	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 214956 application number: ANDA214956
GABAPENTIN	GABAPENTIN	Redpharm Drug	44f2b497-55b2-864f-e063-6294a90ad6d5	2025-12-02	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 214956 application number: ANDA214956
GABAPENTIN	GABAPENTIN	REMEDYREPACK INC.	fbeccab7-08aa-4da3-868f-b47a1f3d41ef	2025-10-08	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 214956 application number: ANDA214956
GABAPENTIN	GABAPENTIN	XLCare Pharmaceuticals, Inc.	618c948d-deee-44e2-98f0-e5232171dd50	2025-08-04	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 214956 application number: ANDA214956
GABAPENTIN	GABAPENTIN	NuCare Pharmaceuticals, Inc.	200b61d7-6e4c-923d-e063-6294a90a42cf	2025-02-21	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 214956 application number: ANDA214956
GABAPENTIN	GABAPENTIN	Bryant Ranch Prepack	35ac6b11-7b1c-47a0-a4ba-c193a0bb5b01	2025-02-20	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 214956 application number: ANDA214956
GABAPENTIN	GABAPENTIN	NuCare Pharmaceuticals,Inc.	2b395a14-0f8e-7f5b-e063-6294a90ab546	2025-01-08	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 214956 application number: ANDA214956
GABAPENTIN	GABAPENTIN	Camber Pharmaceuticals, Inc.	e8a30eb7-3fc5-456a-bdae-3f4095bf2c2b	2024-12-26	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 214956 application number: ANDA214956 ndc (product): 31722-148
GABAPENTIN	GABAPENTIN	Asclemed USA, Inc.	17a62334-209d-4dc1-867a-e5780196a2ca	2024-11-05	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 214956 application number: ANDA214956
GABAPENTIN	GABAPENTIN	Aphena Pharma Solutions - Tennessee, LLC	f38098ec-dd1a-405a-bbfb-bad62e4e7fa5	2024-01-04	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 214956 application number: ANDA214956

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
6CW7F3G59X	GABAPENTIN	60142-96-3	GABAPENTIN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
310430	gabapentin 100 MG Oral Capsule	PSN	e8a30eb7-3fc5-456a-bdae-3f4095bf2c2b	3
310430	gabapentin 100 MG Oral Capsule	PSN	685553b0-384e-400b-a8ae-612ceece8261	3
310430	gabapentin 100 MG Oral Capsule	PSN	7ea0b220-edbb-45eb-aeb3-65283f8489a1	3
310430	gabapentin 100 MG Oral Capsule	PSN	235a6954-318a-9e3a-e063-6394a90a0e21	3
310431	gabapentin 300 MG Oral Capsule	PSN	e8a30eb7-3fc5-456a-bdae-3f4095bf2c2b	3
310432	gabapentin 400 MG Oral Capsule	PSN	e8a30eb7-3fc5-456a-bdae-3f4095bf2c2b	3
310430	gabapentin 100 MG Oral Capsule	SCD	e8a30eb7-3fc5-456a-bdae-3f4095bf2c2b	3
310430	gabapentin 100 MG Oral Capsule	SCD	235a6954-318a-9e3a-e063-6394a90a0e21	3
310430	gabapentin 100 MG Oral Capsule	SCD	7ea0b220-edbb-45eb-aeb3-65283f8489a1	3
310430	gabapentin 100 MG Oral Capsule	SCD	685553b0-384e-400b-a8ae-612ceece8261	3
310431	gabapentin 300 MG Oral Capsule	SCD	e8a30eb7-3fc5-456a-bdae-3f4095bf2c2b	3
310432	gabapentin 400 MG Oral Capsule	SCD	e8a30eb7-3fc5-456a-bdae-3f4095bf2c2b	3
310430	gabapentin 100 MG Oral Capsule	PSN	200b61d7-6e4c-923d-e063-6294a90a42cf	2
310430	gabapentin 100 MG Oral Capsule	PSN	47214c7c-ba1b-9107-e063-6294a90a5431	2
310430	gabapentin 100 MG Oral Capsule	SCD	200b61d7-6e4c-923d-e063-6294a90a42cf	2
310430	gabapentin 100 MG Oral Capsule	SCD	47214c7c-ba1b-9107-e063-6294a90a5431	2
310430	gabapentin 100 MG Oral Capsule	PSN	dd0e12c2-1986-4ca3-a809-d703a7542419	1
310430	gabapentin 100 MG Oral Capsule	PSN	fbeccab7-08aa-4da3-868f-b47a1f3d41ef	1
310430	gabapentin 100 MG Oral Capsule	PSN	44f2b497-55b2-864f-e063-6294a90ad6d5	1
310430	gabapentin 100 MG Oral Capsule	PSN	2b395a14-0f8e-7f5b-e063-6294a90ab546	1
310430	gabapentin 100 MG Oral Capsule	PSN	17a62334-209d-4dc1-867a-e5780196a2ca	1
310431	gabapentin 300 MG Oral Capsule	PSN	17a62334-209d-4dc1-867a-e5780196a2ca	1
310432	gabapentin 400 MG Oral Capsule	PSN	17a62334-209d-4dc1-867a-e5780196a2ca	1
310430	gabapentin 100 MG Oral Capsule	SCD	44f2b497-55b2-864f-e063-6294a90ad6d5	1
310430	gabapentin 100 MG Oral Capsule	SCD	dd0e12c2-1986-4ca3-a809-d703a7542419	1
310430	gabapentin 100 MG Oral Capsule	SCD	2b395a14-0f8e-7f5b-e063-6294a90ab546	1
310430	gabapentin 100 MG Oral Capsule	SCD	17a62334-209d-4dc1-867a-e5780196a2ca	1
310430	gabapentin 100 MG Oral Capsule	SCD	fbeccab7-08aa-4da3-868f-b47a1f3d41ef	1
310431	gabapentin 300 MG Oral Capsule	SCD	17a62334-209d-4dc1-867a-e5780196a2ca	1
310432	gabapentin 400 MG Oral Capsule	SCD	17a62334-209d-4dc1-867a-e5780196a2ca	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
31722-148-01	31722014801	100 CAPSULE in 1 BOTTLE (31722-148-01)	100 capsule	2021-05-10	0000-00-00	No	No	Current
31722-148-05	31722014805	500 CAPSULE in 1 BOTTLE (31722-148-05)	500 capsule	2021-05-10	0000-00-00	No	No	Current
31722-148-10	31722014810	1000 CAPSULE in 1 BOTTLE (31722-148-10)	1000 capsule	2021-05-10	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
GABAPENTIN	St. Mary's Medical Park Pharmacy	2026-06-19	HUMAN PRESCRIPTION DRUG LABEL	4
GABAPENTIN	Preferred Pharmaceuticals Inc.	2026-04-22	HUMAN PRESCRIPTION DRUG LABEL	1
GABAPENTIN	A-S Medication Solutions	2026-01-22	HUMAN PRESCRIPTION DRUG LABEL	3
GABAPENTIN	A-S Medication Solutions	2026-01-22	HUMAN PRESCRIPTION DRUG LABEL	3
GABAPENTIN	Northwind Health Company, LLC	2025-12-29	HUMAN PRESCRIPTION DRUG LABEL	2
GABAPENTIN	Redpharm Drug	2025-12-02	HUMAN PRESCRIPTION DRUG LABEL	1
GABAPENTIN	REMEDYREPACK INC.	2025-10-08	HUMAN PRESCRIPTION DRUG LABEL	1
GABAPENTIN	NuCare Pharmaceuticals, Inc.	2025-02-21	HUMAN PRESCRIPTION DRUG LABEL	2
GABAPENTIN	NuCare Pharmaceuticals,Inc.	2025-01-08	HUMAN PRESCRIPTION DRUG LABEL	1
GABAPENTIN	Camber Pharmaceuticals, Inc. \| Hetero Labs Limited, Vemagal	2024-12-26	HUMAN PRESCRIPTION DRUG LABEL	3
GABAPENTIN	Asclemed USA, Inc. \| ASCLEMED USA INC. DBA ENOVACHEM	2024-11-05	HUMAN PRESCRIPTION DRUG LABEL	1